Opko Health, Inc.
OPK
$1.34
-$0.05-3.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.75% | -7.31% | -13.78% | -17.41% | -17.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.75% | -7.31% | -13.78% | -17.41% | -17.94% |
| Cost of Revenue | -15.13% | -11.95% | -9.57% | -9.62% | -4.17% |
| Gross Profit | 19.59% | 20.88% | -28.07% | -39.06% | -53.96% |
| SG&A Expenses | -22.76% | -0.07% | -0.66% | 1.22% | 2.78% |
| Depreciation & Amortization | -5.49% | -5.65% | -5.74% | -3.95% | -2.70% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.16% | -5.34% | -4.01% | -3.41% | 0.58% |
| Operating Income | 30.91% | 0.06% | -35.25% | -73.07% | -108.98% |
| Income Before Tax | -35.34% | 37.67% | 99.77% | 94.37% | 44.96% |
| Income Tax Expenses | 31.59% | 1,664.42% | 1,972.44% | 865.58% | 343.56% |
| Earnings from Continuing Operations | -34.89% | 27.13% | 84.55% | 71.82% | 35.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.89% | 27.13% | 84.55% | 71.82% | 35.58% |
| EBIT | 30.91% | 0.06% | -35.25% | -73.07% | -108.98% |
| EBITDA | 42.44% | -4.47% | -83.70% | -232.41% | -394.77% |
| EPS Basic | -31.26% | 29.83% | 82.79% | 70.51% | 33.68% |
| Normalized Basic EPS | 58.52% | 22.73% | 75.87% | 61.35% | -9.79% |
| EPS Diluted | -28.20% | 28.30% | 80.87% | 68.04% | 31.22% |
| Normalized Diluted EPS | 36.41% | 20.04% | 73.02% | 57.34% | 3.62% |
| Average Basic Shares Outstanding | 2.22% | -2.62% | -7.48% | -7.68% | -5.15% |
| Average Diluted Shares Outstanding | 1.19% | 17.29% | 12.07% | 11.58% | 4.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |